Central GABAergic control of cardiac function in different hypertrophy models

Area of Science:

• Cardiovascular Physiology
• Neuroscience
• GABAergic Signaling

Background:

• Cardiac hypertrophy precedes heart failure and involves complex peripheral and central mechanisms.
• The role of central GABAergic system changes in response to pressure overload and beta-adrenergic stimulation in cardiac hypertrophy remains unclear.

Purpose of the Study:

• To investigate the link between cardiac hypertrophy models and central GABAergic alterations.
• To compare different hypertrophy models: aortic coarctation (COA), isoproterenol (ISO) stimulation, and spontaneously hypertensive rats (SHR).

Main Methods:

• Induction of cardiac hypertrophy in Wistar rats via COA and ISO, and use of SHR.
• Hemodynamic recordings and intracerebroventricular injections of GABA and L-allylglycine (LAG).
• Analysis of gene and protein expression of GABAergic components (VGAT, GAD65/67, GABA receptors) in the hypothalamus and medulla.

Main Results:

• All hypertrophy models (SHR, ISO, COA) exhibited cardiac hypertrophy and dysfunction, with SHR showing the most severe changes.
• GABA administration reduced blood pressure and contractility across all models.
• SHR displayed elevated hypothalamic GABAergic gene expression and protein levels (GABA_A), and reduced medullary GABA_B levels, indicating significant central GABAergic alterations.

Conclusions:

• Spontaneously hypertensive rats represent a relevant model for studying hypertrophy-induced central nervous system changes.
• Alterations in hypothalamic and medullary GABAergic systems are prominent in SHR, suggesting a role in the pathophysiology of cardiac hypertrophy.